Monitoring treatment response in lung cancer patients with glycodelin
Patients have regular check-ups during and after lung cancer treatment to see whether the treatment is successful in the long term - or whether the…
March - TLRC congratulates PI Prof. Rory Morty to his appointment as chief editor of European Respiratory Review Journal
The TLRC congratulates DZL Principal Investigator Professor Rory Morty to his appointment as chief editor of the ERS Journal European Respiratory…
Research into Alpha-1-Antitrypsin Deficiency and Improvement of Clinical Treatment Options.
We are pleased to announce that TLRC early career clinicians Arturo Olivares-Rivera and Dr. Philipp Höger, from the Thoraxklinik Heidelberg, have been…
TLRC researcher Uwe Haberkorn is again among the most cited scientists worldwide
Seven DZL scientists are among the most cited researchers worldwide in 2023 according to the Clarivate Analytics list of "Highly Cited Researchers".…
TLRC junior scientist receives 2nd prize for scientific abstract in the field of interstitial lung diseases.
The DPLD Young Investigator Meeting took place on 17 November 2023 at the DZL-site Heidelberg.
37 young scientists had the opportunity to present…
ESTI Best Oral Presentation Award to Dr. Lena Wucherpfennig
We congratulate Dr. Lena Wucherpfennig for receiving the Best Oral Presentation Award at the annual conference of the Europoean Society for Thoracic…
Epigenetically acting drugs could support cancer immunotherapy
DZL-scientist Christoph Plass and his team have successfully used epigenetically acting drugs to increase the recognition of cancer cells by the…
![[Translate to English:]](/fileadmin/_processed_/6/b/csm_Ann_Katrin_Daum_7d7f6774b2.jpg "[Translate to English:]")
Takeda Research Award 2023 to Dr. Ann-Katrin Daum
We are happy to announce that DZL Academy Fellow Ann-Katrin Daum, (German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)…